Home/Filings/4/0001104659-25-021732
4//SEC Filing

Divis Gregory J 4

Accession 0001104659-25-021732

CIK 0001012477other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:06 PM ET

Size

8.4 KB

Accession

0001104659-25-021732

Insider Transaction Report

Form 4
Period: 2025-03-05
DIVIS GREG J
DirectorChief Executive Officer
Transactions
  • Award

    Ordinary Shares

    2025-03-05+52,000211,100 total
  • Award

    Stock Option (Right to Buy)

    2025-03-05+310,000310,000 total
    Exercise: $7.87Exp: 2030-03-06Ordinary Shares (310,000 underlying)
Holdings
  • Ordinary Shares

    (indirect: By Trust)
    10,000
Footnotes (3)
  • [F1]Consists of a restricted share award. The restricted share award shall vest in equal annual installments on each of the first four anniversaries following the 3/5/2025 grant date.
  • [F2]These Ordinary Shares are held by the Gregory J. Divis Jr. Revocable Trust, of which the Reporting Person is trustee and beneficiary.
  • [F3]The options shall vest, if at all, in four equal increments if the volume-weighted average price of the Issuer's Ordinary Shares during any 30 calendar day period exceeds $11, $14, $17 and $19.09, respectively.

Issuer

AVADEL PHARMACEUTICALS PLC

CIK 0001012477

Entity typeother

Related Parties

1
  • filerCIK 0001410677

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:06 PM ET
Size
8.4 KB